Agenda Wednesday July 12, 2023
Spire Global, Inc. (NYSE: SPIR) is a global provider of space-based data, analytics and space services, offering unique datasets and powerful insights about Earth so that organizations can make decisions with confidence in a rapidly changing world.
Keynote speaker: Peter Platzer, CEO
OHB SE (Frankfurt: OHB) is comprised of three business units: Space Systems, Aerospace, and Digital. The group employs a workforce of almost 3,000 at 15 locations throughout Europe.
Keynote speaker: Marco Fuchs, CEO
ReWalk Robotics Ltd. (NASDAQ: RWLK) is a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions.
Keynote speaker: Larry Jasinski, CEO
SS Innovations International, Inc. (OTC Pink: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population.
Keynote speaker: Dr. Srivastava, Chairman & CEO
GlobeStar Therapeutics Corporation’s (OTC PINK:GSTC) mission is to pioneer biotechnology in transformative therapies for the management of chronic neurodegenerative diseases.
Keynote speaker: James Katzaroff, President / CEO
DBMM Group (OTC Pink: DBMM) is a leading provider of marketing consulting and advisory solutions, through its operating brand, Digital Clarity. Digital Clarity empowers businesses to achieve their marketing goals through strategic insights, innovative use of technologies, AI, and exceptional customer service. With a strong track record of success and a commitment to delivering tangible results, Digital Clarity is at the forefront of driving marketing change, driving growth, and creating lasting value for its clients. The stock ticker is DBMM. For more information on Digital Clarity visit digital-clarity.com
Keynote speaker: Reggie James, COO, Sr. VP & Exec. Director
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.
Keynote speaker: David P. Luci, President & CEO
Sweet Poison Spirits (CSE: SPS) is committed to the creation and distribution of high quality products, respecting artisanal and ancestral processes, sustainability, the environment, and prioritizing fair trade, thus supporting the economic growth of different populations of our Mexico.
Keynote speaker: Robert Eadie, CEO
Kodiak Copper Corp. (OTCQB: KDKCF) (TSXV: KDK) is focused on its 100% owned copper porphyry projects in Canada and the USA. The Company’s most advanced asset is the MPD copper-gold porphyry project in the prolific Quesnel Trough in south-central British Columbia, Canada.
Keynote speaker: Claudia Tornquist, CEO
Intellabridge Technology Corporation (OTCQB: KASHF) (CSE: KASH) (FSE: KASH) is a fintech company in the business of impact finance with a mission to make every transaction have a positive impact on the world through cashback solutions and automated customizable donations to charitable organizations based on the United Nations Sustainable Development Goals.
Keynote speaker: John Eagleton, CEO
dynaCERT Inc. (OTCQX: DYFSF) (TSX: DYA) manufactures and distributes Carbon Emission Reduction Technology along with its proprietary HydraLytica™ Telematics, a means of monitoring fuel consumption and calculating GHG emissions savings designed for the tracking of possible future Carbon Credits for use with internal combustion engines.
Keynote speaker: James Payne President / CEO & Director
Agenda Thursday July 13, 2023
AdAlta (ASX: 1AD) is an innovative, clinical stage biotech company developing a unique range of new drug treatments.
Keynote speaker: Tim Oldham, Managing Director
Cerrado Gold (OTCQX: CRDOF) (TSXV: CERT) is a Toronto-based gold production, development, and exploration company focused on gold projects in South America.
Keynote speaker: Mike McAllister VP investor Relations
CoTec Holdings Corp. (OTCQB: CTHCF) (TSXV: CTH) trades on the OTCQB under the symbol CTHCF and on the TSXV under the symbol CERT and is an ESG-focused company investing in innovative technologies that have the potential to fundamentally change the way metals and minerals can be extracted and processed.
Keynote speaker: John Singleton, COO
Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. The leading drug candidate, Prolectin-M, is a new class of antiviral drug designed to antagonize galectins implicated in inflammatory, fibrotic, and malignant diseases.
Keynote speaker: Mike Sheikh, Executive Vice President Business Development
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease.
Keynote speakers: Motti Farbstein, CEO, CFO
Bright Mountain Media, Inc. (OTCQB: BMTM) unites a diverse portfolio of companies to deliver a full spectrum of advertising, marketing, technology, and media services under one roof—fused together by data-driven insights.
Keynote speaker: Matthew Drinkwater, CEO
Altus Gold has executed an LOI with Scorpio Gold (TSXV: SGN), (OTC Pink: SRCRF) and where Scorpio will acquire Altus Gold via reverse merger. The combined entities will be renamed Altus Gold Corp, with the Altus Gold team assuming management and control of Scorpio Gold at closing.
Keynote speaker: Michael Townsend, CEO
Renforth Resources, Inc. (OTCQB: RFHRF) (CSE: RFR) is a secure multi-commodity area play with the dominant brownfield land position south of the world class Cadillac-Larder Lake Fault (“CLLF”) in the prolific Cadillac and Malartic mining camps of Quebec’s Abitibi.
Keynote speaker: Nicole Brewster, President & CEO
The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.
Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.
The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.
Thank you for your interest in our conference, and we look forward to your participation in future conferences.
